Stock 9776 SAPPORO CLINICAL LABORATORY INC.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Sapporo Clinical Laboratory Inc.

Equities

9776

JP3321100004

Delayed Japan Exchange
Other stock markets
 20:26:24 2024-05-20 EDT 		5-day change 1st Jan Change
995 JPY +0.40% Intraday chart for Sapporo Clinical Laboratory Inc. -7.44% -0.60%
03-27 Tranche Update on Sapporo Clinical Laboratory Inc.'s Equity Buyback Plan announced on February 26, 2024. CI
03-26 Sapporo Clinical Laboratory Inc.'s Equity Buyback announced on March 26, 2024, has closed with 210,800 shares, representing 6.33% for ¥189.93 million. CI

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Tranche Update on Sapporo Clinical Laboratory Inc.'s Equity Buyback Plan announced on February 26, 2024.
CI
Sapporo Clinical Laboratory Inc.'s Equity Buyback announced on March 26, 2024, has closed with 210,800 shares, representing 6.33% for ¥189.93 million.
CI
Sapporo Clinical Laboratory Inc. announces an Equity Buyback for 232,100 shares, representing 6.97% for ¥209.12 million.
CI
Sapporo Clinical Laboratory Inc. authorizes a Buyback Plan.
CI
Sapporo Clinical Laboratory Inc. Reports Earnings Results for the Full Year Ended March 31, 2023
CI
Tranche Update on Sapporo Clinical Laboratory Inc.'s Equity Buyback Plan announced on May 30, 2022.
CI
Sapporo Clinical Laboratory Inc.'s Equity Buyback announced on May 30, 2022 has closed with 22,700 shares, representing 0.67% for ¥29.21 million.
CI
Sapporo Clinical Laboratory Inc. announces an Equity Buyback for 22,700 shares, representing 0.68% for ¥29.21 million.
CI
Sapporo Clinical Laboratory Inc. authorizes a Buyback Plan.
CI
Tranche Update on Sapporo Clinical Laboratory Inc.'s Equity Buyback Plan announced on February 28, 2022.
CI
Sapporo Clinical Laboratory Inc.'s Equity Buyback announced on February 28, 2022, has closed with 53,700 shares, representing 1.58% for ¥69.11 million.
CI
Sapporo Clinical Laboratory Inc. announces an Equity Buyback for 53,700 shares, representing 1.58% for ¥69.11 million.
CI
Sapporo Clinical Laboratory Inc. authorizes a Buyback Plan.
CI
Tranche Update on Sapporo Clinical Laboratory Inc.'s Equity Buyback Plan announced on June 21, 2021.
CI
Sapporo Clinical Laboratory Inc.'s Equity Buyback announced on June 21, 2021, has closed with 16,300 shares, representing 0.48% for ¥25.92 million.
CI
Sapporo Clinical Laboratory Inc. announces an Equity Buyback for 16,300 shares, representing 0.48% for ¥25.92 million.
CI
Sapporo Clinical Laboratory Inc. authorizes a Buyback Plan.
CI
Tranche Update on Sapporo Clinical Laboratory Inc.'s Equity Buyback Plan announced on June 26, 2018.
CI
Sapporo Clinical Laboratory Inc.'s Equity Buyback announced on June 26, 2018 has expired with 39,200 shares, representing 1.13% for ¥96 million.
CI
Sapporo Clinical Laboratory Inc. announces an Equity Buyback for 45,000 shares, representing 1.3% for ¥110.21 million.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 9776 Stock
  4. News Sapporo Clinical Laboratory Inc.
  5. Highlights
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW